Regression of hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection

Abstract

Links between hepatitis C virus (HCV) infection and several non-Hodgkin lymphomas have been sug-gested by epidemiological studies. We herein report the first documented case of a patient with HCV-associated Hodgkin lymphoma who showed a marked regression following interferon-based antiviral therapy. This unique case extends the spectrum of HCV-associated malignant lymphomas, confirms the efficacy of an-tiviral therapy for this rare extrahepatic manifestation and provides valuable clues for achieving a better un-derstanding of lymphomagenesis in HCV. © 2012 The Japanese Society of Internal Medicine.